vs
OptimizeRx Corp(OPRX)与REGIS CORP(RGS)财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是OptimizeRx Corp的1.8倍($57.1M vs $32.2M),OptimizeRx Corp净利率更高(15.6% vs 0.8%,领先14.8%),REGIS CORP同比增速更快(22.3% vs -0.2%),OptimizeRx Corp自由现金流更多($7.1M vs $891.0K),过去两年OptimizeRx Corp的营收复合增速更高(28.0% vs 7.8%)
OptimizeRx Corp是一家总部位于美国的数字健康科技企业,为生命科学公司、医疗机构及药房合作伙伴提供患者参与、药物可负担性和临床沟通相关解决方案,核心产品包括数字购药优惠工具、患者支持项目等,助力提升药物可及性与用药依从性。
瑞吉斯公司是一家美国美发沙龙运营商,总部位于明尼苏达州明尼阿波利斯市。截至2021年8月,该集团旗下拥有5563家加盟沙龙以及276家直营门店,是北美地区规模领先的美发沙龙连锁经营企业。
OPRX vs RGS — 直观对比
营收规模更大
RGS
是对方的1.8倍
$32.2M
营收增速更快
RGS
高出22.5%
-0.2%
净利率更高
OPRX
高出14.8%
0.8%
自由现金流更多
OPRX
多$6.2M
$891.0K
两年增速更快
OPRX
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $32.2M | $57.1M |
| 净利润 | $5.0M | $456.0K |
| 毛利率 | 74.8% | — |
| 营业利润率 | 26.6% | 10.8% |
| 净利率 | 15.6% | 0.8% |
| 营收同比 | -0.2% | 22.3% |
| 净利润同比 | 6535.9% | -94.0% |
| 每股收益(稀释后) | $0.27 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
OPRX
RGS
| Q4 25 | $32.2M | $57.1M | ||
| Q3 25 | $26.1M | $59.0M | ||
| Q2 25 | $29.2M | $60.4M | ||
| Q1 25 | $21.9M | $57.0M | ||
| Q4 24 | $32.3M | $46.7M | ||
| Q3 24 | $21.3M | $46.1M | ||
| Q2 24 | $18.8M | $49.4M | ||
| Q1 24 | $19.7M | $49.2M |
净利润
OPRX
RGS
| Q4 25 | $5.0M | $456.0K | ||
| Q3 25 | $779.0K | $1.4M | ||
| Q2 25 | $1.5M | $116.5M | ||
| Q1 25 | $-2.2M | $250.0K | ||
| Q4 24 | $-78.0K | $7.6M | ||
| Q3 24 | $-9.1M | $-853.0K | ||
| Q2 24 | $-4.0M | $91.2M | ||
| Q1 24 | $-6.9M | $-2.3M |
毛利率
OPRX
RGS
| Q4 25 | 74.8% | — | ||
| Q3 25 | 67.2% | — | ||
| Q2 25 | 63.8% | — | ||
| Q1 25 | 60.9% | — | ||
| Q4 24 | 68.1% | — | ||
| Q3 24 | 63.1% | — | ||
| Q2 24 | 62.2% | — | ||
| Q1 24 | 62.0% | — |
营业利润率
OPRX
RGS
| Q4 25 | 26.6% | 10.8% | ||
| Q3 25 | 7.9% | 10.0% | ||
| Q2 25 | 10.9% | 12.1% | ||
| Q1 25 | -9.6% | 8.8% | ||
| Q4 24 | 11.2% | 11.8% | ||
| Q3 24 | -40.2% | 4.6% | ||
| Q2 24 | -19.9% | — | ||
| Q1 24 | -25.5% | 8.3% |
净利率
OPRX
RGS
| Q4 25 | 15.6% | 0.8% | ||
| Q3 25 | 3.0% | 2.3% | ||
| Q2 25 | 5.2% | 192.9% | ||
| Q1 25 | -10.0% | 0.4% | ||
| Q4 24 | -0.2% | 16.4% | ||
| Q3 24 | -42.8% | -1.9% | ||
| Q2 24 | -21.3% | 184.7% | ||
| Q1 24 | -35.0% | -4.7% |
每股收益(稀释后)
OPRX
RGS
| Q4 25 | $0.27 | $0.16 | ||
| Q3 25 | $0.04 | $0.49 | ||
| Q2 25 | $0.08 | $43.67 | ||
| Q1 25 | $-0.12 | $0.08 | ||
| Q4 24 | $0.00 | $2.71 | ||
| Q3 24 | $-0.50 | $-0.36 | ||
| Q2 24 | $-0.22 | $38.40 | ||
| Q1 24 | $-0.38 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $23.4M | $18.4M |
| 总债务越低越好 | $26.3M | $113.3M |
| 股东权益账面价值 | $128.3M | $188.7M |
| 总资产 | $176.9M | $588.3M |
| 负债/权益比越低杠杆越低 | 0.20× | 0.60× |
8季度趋势,按日历期对齐
现金及短期投资
OPRX
RGS
| Q4 25 | $23.4M | $18.4M | ||
| Q3 25 | $19.5M | $16.6M | ||
| Q2 25 | $16.6M | $17.0M | ||
| Q1 25 | $16.6M | $13.3M | ||
| Q4 24 | $13.4M | $10.2M | ||
| Q3 24 | $16.1M | $6.3M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.9M |
总债务
OPRX
RGS
| Q4 25 | $26.3M | $113.3M | ||
| Q3 25 | $28.8M | $111.3M | ||
| Q2 25 | $29.3M | $110.8M | ||
| Q1 25 | $33.8M | $112.0M | ||
| Q4 24 | $34.3M | $111.5M | ||
| Q3 24 | $36.8M | $95.2M | ||
| Q2 24 | $37.3M | $99.5M | ||
| Q1 24 | $37.8M | $179.7M |
股东权益
OPRX
RGS
| Q4 25 | $128.3M | $188.7M | ||
| Q3 25 | $122.3M | $187.6M | ||
| Q2 25 | $119.3M | $185.6M | ||
| Q1 25 | $116.3M | $68.6M | ||
| Q4 24 | $117.0M | $66.7M | ||
| Q3 24 | $114.5M | $56.4M | ||
| Q2 24 | $121.0M | $56.8M | ||
| Q1 24 | $122.5M | $-35.8M |
总资产
OPRX
RGS
| Q4 25 | $176.9M | $588.3M | ||
| Q3 25 | $170.3M | $592.1M | ||
| Q2 25 | $169.3M | $599.0M | ||
| Q1 25 | $167.8M | $511.2M | ||
| Q4 24 | $171.2M | $530.1M | ||
| Q3 24 | $165.2M | $508.9M | ||
| Q2 24 | $172.9M | $530.5M | ||
| Q1 24 | $176.4M | $543.7M |
负债/权益比
OPRX
RGS
| Q4 25 | 0.20× | 0.60× | ||
| Q3 25 | 0.24× | 0.59× | ||
| Q2 25 | 0.25× | 0.60× | ||
| Q1 25 | 0.29× | 1.63× | ||
| Q4 24 | 0.29× | 1.67× | ||
| Q3 24 | 0.32× | 1.69× | ||
| Q2 24 | 0.31× | 1.75× | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $7.1M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $7.1M | $891.0K |
| 自由现金流率自由现金流/营收 | 22.0% | 1.6% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 1.41× | 3.65× |
| 过去12个月自由现金流最近4个季度 | $18.7M | $14.9M |
8季度趋势,按日历期对齐
经营现金流
OPRX
RGS
| Q4 25 | $7.1M | $1.7M | ||
| Q3 25 | $3.2M | $2.3M | ||
| Q2 25 | $4.6M | $6.8M | ||
| Q1 25 | $3.9M | $6.2M | ||
| Q4 24 | $198.0K | $2.1M | ||
| Q3 24 | $1.8M | $-1.3M | ||
| Q2 24 | $782.0K | $5.1M | ||
| Q1 24 | $2.1M | $-277.0K |
自由现金流
OPRX
RGS
| Q4 25 | $7.1M | $891.0K | ||
| Q3 25 | $3.2M | $1.9M | ||
| Q2 25 | $4.6M | $6.2M | ||
| Q1 25 | $3.8M | $5.9M | ||
| Q4 24 | $181.0K | $1.7M | ||
| Q3 24 | $1.8M | $-1.4M | ||
| Q2 24 | $737.0K | $5.1M | ||
| Q1 24 | $2.1M | $-326.0K |
自由现金流率
OPRX
RGS
| Q4 25 | 22.0% | 1.6% | ||
| Q3 25 | 12.2% | 3.2% | ||
| Q2 25 | 15.6% | 10.3% | ||
| Q1 25 | 17.5% | 10.3% | ||
| Q4 24 | 0.6% | 3.6% | ||
| Q3 24 | 8.3% | -3.0% | ||
| Q2 24 | 3.9% | 10.3% | ||
| Q1 24 | 10.6% | -0.7% |
资本支出强度
OPRX
RGS
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.1% | 0.9% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率
OPRX
RGS
| Q4 25 | 1.41× | 3.65× | ||
| Q3 25 | 4.11× | 1.68× | ||
| Q2 25 | 2.98× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPRX
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |